Clinical Trial Update: Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two fixed-dose combinations of telmisartan/amlodipine (80/5 and 40/5) with amlodipine alone (5 or 10 mg) in resistant hypertension; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine 10 (amlodipine)
• Amlodipine 5 (amlodipine)
• Telmisartan/amlodipine 40/5 (telmisartan/amlodipine)
• Telmisartan/amlodipine 80/5 (telmisartan/amlodipine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-12-15